Open original FDA record ↗Recall record
- FDA identifier
- Z-0592-2018
- Company in FDA record
- Cepheid
- FDA record creation date
- Feb 12, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains consistent with package insert claims.
Source facts
- Action
- An Urgent Medical Device Recall letter (response form included), dated October 9, 2017, was sent to affected consignees. The letter identified the affected product, the issue involved, impact, and actions to be taken. Cepheid will provide replacement product for Xpert CT/NG assay product identified in this recall. Customers are to complete and the return the Response Form provided in order to receive replacement product. Additionally, the letter instructs users to review their laboratory statistics to see if their positivity rates are trending low during use of the affected lots. If so, they are to review the negative patient results according to their laboratory's Quality Management System. Customers are to refer to the applicable contact information provided if there are any questions.
- Initiated
- 2017-10-09
- Root cause
- Equipment maintenance
- Terminated
- 2018-02-13
- Distribution
- Worldwide Distribution -- USA, Puerto Rico, and Haiti.
- Recall number
- Z-0592-2018
- Recall status
- Terminated
- CDRH record ID
- 160839
- FDA record created
- 2018-02-12
- Recall event number
- 78910